South Korea · Delayed Price · Currency is KRW Oncocross Statistics
Total Valuation
Oncocross has a market cap or net worth of KRW 146.98 billion. The enterprise value is 131.02 billion.
| Market Cap | 146.98B |
| Enterprise Value | 131.02B |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oncocross has 12.02 million shares outstanding. The number of shares has increased by 15.62% in one year.
| Current Share Class | 12.02M |
| Shares Outstanding | 12.02M |
| Shares Change (YoY) | +15.62% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 27.15% |
| Owned by Institutions (%) | 11.05% |
| Float | 6.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 141.56 |
| PB Ratio | 8.57 |
| P/TBV Ratio | 8.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.10 |
| EV / Sales | 126.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.34 |
Financial Position
The company has a current ratio of 14.88, with a Debt / Equity ratio of 0.02.
| Current Ratio | 14.88 |
| Quick Ratio | 14.81 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -268.96 |
Financial Efficiency
Return on equity (ROE) is -49.39% and return on invested capital (ROIC) is -32.00%.
| Return on Equity (ROE) | -49.39% |
| Return on Assets (ROA) | -30.09% |
| Return on Invested Capital (ROIC) | -32.00% |
| Return on Capital Employed (ROCE) | -46.98% |
| Revenue Per Employee | 33.49M |
| Profits Per Employee | -247.14M |
| Employee Count | 31 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 9,677.00 |
| 200-Day Moving Average | 10,855.10 |
| Relative Strength Index (RSI) | 67.32 |
| Average Volume (20 Days) | 1,330,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oncocross had revenue of KRW 1.04 billion and -7.66 billion in losses. Loss per share was -682.73.
| Revenue | 1.04B |
| Gross Profit | 758.82M |
| Operating Income | -8.10B |
| Pretax Income | -7.66B |
| Net Income | -7.66B |
| EBITDA | -7.59B |
| EBIT | -8.10B |
| Loss Per Share | -682.73 |
Balance Sheet
The company has 16.34 billion in cash and 373.60 million in debt, giving a net cash position of 15.96 billion or 1,328.20 per share.
| Cash & Cash Equivalents | 16.34B |
| Total Debt | 373.60M |
| Net Cash | 15.96B |
| Net Cash Per Share | 1,328.20 |
| Equity (Book Value) | 17.16B |
| Book Value Per Share | 1,436.06 |
| Working Capital | 15.36B |
Cash Flow
In the last 12 months, operating cash flow was -6.47 billion and capital expenditures -1.08 billion, giving a free cash flow of -7.56 billion.
| Operating Cash Flow | -6.47B |
| Capital Expenditures | -1.08B |
| Free Cash Flow | -7.56B |
| FCF Per Share | -628.70 |
Margins
| Gross Margin | 73.09% |
| Operating Margin | -780.61% |
| Pretax Margin | -737.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Oncocross does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.62% |
| Shareholder Yield | -15.62% |
| Earnings Yield | -5.21% |
| FCF Yield | -5.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oncocross has an Altman Z-Score of 61.72 and a Piotroski F-Score of 4.
| Altman Z-Score | 61.72 |
| Piotroski F-Score | 4 |